穿皮冠状动脉干预后绝对冠状动脉血流和心肌抵抗的变化
Federico Marin1,2, Samer Fawaz2,3, Rafail A Kotronias4
1Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, United Kingdom.
概括
穿皮冠状动脉干预 (PCI) 降低了心表抵抗力,增加了高血压的流量. 静止冠状动脉流没有变化,这是由于微血管阻力增加的补偿,这表明人体冠状动脉流的自我调节.
科学领域:
- 心血管生理学心血管生理学
- 干预性心脏病学 干预性心脏病学
- 医疗器械技术 医疗器械技术
背景情况:
- 穿皮冠状动脉干预 (PCI) 旨在通过增强冠状动脉血流来改善心肌缺血.
- 在PCI之后冠状动脉流量和阻力的精确变化尚未完全阐明.
研究的目的:
- 调查PCI对绝对冠状动脉流量 (Q) 以及表心 (Repi) 和微血管 (Rμ) 抵抗的直接影响.
- 评估分量流量储备 (FFR) 和PCI后冠状动力学之间的关系.
主要方法:
- 这是一项前性,两中心的研究,涉及52名接受PCI的患者.
- 生理学评估使用连续热稀释,使用压力-温度传感器线和输液微导管进行输液.
主要成果:
- 静止冠状动脉流量 (Q) 在PCI后没有显著变化 (p=0.21).
- 副心电阻 (Repi) 在休息状态和高血压期间显著下降 (p<0.001).
- 微血管抵抗 (Rμ) 在休息时增加 (p=0.002),但在高血压时保持稳定 (p=0.87).
- 在PCI后,高血压流量显著增加 (p<0.001).
- 微血管抵抗储备 (MRR) 保持不变 (p=0.301).
- FFR与Repi有很强的相关性,并预测了高血压流的改善.
结论:
- PCI有效地降低了表心电阻,导致冠状动脉高血压流量的增加,FFR可以预测.
- 不变的静止流被归因于微血管阻力增加的补偿,这表明人类冠状动脉自调节.
- 不受影响的MRR证实了其作为微血管功能的特定指标的作用.
更多相关视频
05:07Author Spotlight: Improved Localization and Monitoring of Coronary Flow Reserve Using Modified PLAX View in Mice
Published on: August 25, 2023
2.1K
06:39Ultrasound Based Assessment of Coronary Artery Flow and Coronary Flow Reserve Using the Pressure Overload Model in Mice
Published on: April 13, 2015
15.8K
相关概念视频
01:27Coronary Artery Disease V: Interprofessional Care
347
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
347
01:28Acute Coronary Syndrome IV: Interprofessional Care
349
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
349
01:30Acute Coronary Syndrome III: Diagnostic Studies
342
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
342
01:29Pathophysiology of Cardiac Performance
1.7K
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.7K
01:30Acute Coronary Syndrome I: Introduction
1.3K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.3K
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
570
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
570